Completed PHASE4 INTERVENTIONAL 2-arm NCT00307463

Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation

Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation: a Randomised, Prospective and Controlled Study

Sponsor: Ege University

Conditions End-stage Renal Disease

Interventions antihypertensive drugs administration strict volume control policy

Updated 6 times since 2017 Last updated: Sep 6, 2013 Started: Sep 30, 2005 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00307463, this PHASE4 trial focuses on End-stage Renal Disease and remains completed. Sponsored by Ege University, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ege University

Data source: Ege University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Adana, Turkey (Türkiye)
• Bornova, Turkey (Türkiye)